Related Experiment Videos
[Placebo in drug clinical trials]
F García-Alonso1, E Guallar, O M Bakke
1Centro Nacional de Farmacobiología, Instituto de Salud Carlos III, Madrid.
Medicina Clinica
|March 11, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
The cohabitation of academia and industry: What position do the medical journals take regarding opinion articles?
Revista clinica espanola·2016
Lower-normal TSH is associated with better metabolic risk factors: A cross-sectional study on Spanish men.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2015
In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci.
The Journal of antimicrobial chemotherapy·2014
In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria.
Antimicrobial agents and chemotherapy·2013
Lymphoblastic lymphoma in adults: diagnosis, prognosis and treatment.
Medicina clinica·2026
Antitumor activity of scorpion venom-derived peptides: A meta-analysis of preclinical studies.
Pharmacological research·2026
Symptom prevalence and pharmacological management of late-stage Parkinson's disease (LSPD): a cross-sectional, multinational survey.
Journal of neural transmission (Vienna, Austria : 1996)·2026
Successful rescue of a patient with extensive lethal-dose aluminum phosphide poisoning complicated by multiple organ dysfunction syndrome.
The Journal of international medical research·2026